Glympse Bio Companies
Glympse Bio is a clinical stage company developing novel, non-invasive, urine-based tests to detect nonalcoholic steatohepatitis (NASH) and cancer.Glympse Bio | Catalio Capital Managementwww.cataliocapital.com/portfolio/glympse-bio
Investors
Technology:
Companies
Industry:
AI R&D Pharma (DPI)
Headquarters:
Cambridge, Cambridgeshire, Cambridgeshire and Peterborough, England, United Kingdom
Founded Date:
2015
Register and Claim Ownership